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The polyamines putrescine, spermidine, and spermine are organic cations that are required for cell growth
and differentiation. Ornithine decarboxylase (ODC), the first and rate-limiting enzyme in the polyamine
biosynthetic pathway, catalyzes the conversion of ornithine to putrescine. As the polyamine biosynthetic
pathway is essential for the growth and survival of Leishmania donovani, the causative agent of visceral
leishmaniasis, inhibition of the pathway is an important leishmaniacidal strategy. In the present study, we
examined for the first time the effects of 3-aminooxy-1-aminopropane (APA), an ODC inhibitor, on the growth
of L. donovani. APA inhibited the growth of both promastigotes in vitro and amastigotes in the macrophage
model, with the 50% inhibitory concentrations being 42 and 5 M, respectively. However, concentrations of
APA up to 200 M did not affect the viability of macrophages. The effects of APA were completely abolished
by the addition of putrescine or spermidine. APA induced a significant decrease in ODC activity and
putrescine, spermidine, and trypanothione levels in L. donovani promastigotes. Parasites were transfected with
an episomal ODC construct, and these ODC overexpressers exhibited significant resistance to APA and were
concomitantly resistant to sodium antimony gluconate (Pentostam), indicating a role for ODC overexpression
in antimonial drug resistance. Clinical isolates with sodium antimony gluconate resistance were also found to
overexpress ODC and to have significant increases in putrescine and spermidine levels. However, no increase
in trypanothione levels was observed. The ODC overexpression in these clinical isolates alleviated the anti-
proliferative effects of APA. Collectively, our results demonstrate that APA is a potent inhibitor of L. donovani
growth and that its leishmaniacidal effect is due to inhibition of ODC.
Leishmaniasis, caused by a protozoan parasite, constitutes a
wide spectrum of diseases ranging from the simple self-limiting
cutaneous form to the debilitating visceral form, which is often
fatal if it is left untreated. Although pentavalent antimonials
(sodium antimony gluconate [SAG]) are the standard first-line
treatments for visceral leishmaniasis (VL) (30), in more recent
times, increasing resistance to SAG has emerged as a major
barrier in the treatment of VL. There has been an epidemic of
primary resistance to SAG in parts of India (30), and an urgent
need exists to look for newer and more effective drugs.
The polyamine biosynthetic pathway is one such pathway
that has been exploited successfully for the development of
antiparasitic drugs (18). Polyamines are organic cations re-
quired for cell growth and differentiation (31). Ornithine de-
carboxylase (ODC), the first and rate-limiting enzyme in the
polyamine biosynthetic pathway, catalyzes the conversion of
ornithine to putrescine (21), and therefore, its inhibition offers
a promising approach to antiparasitic therapy (18). -Difluo-
romethylornithine (DFMO), the enzyme-activated, irrevers-
ible ODC inhibitor, is an effective trypanocidal drug for the
treatment of patients with West African sleeping sickness (18),
even those refractory to currently available antitrypanosomal
drugs and those with central nervous system involvement (22).
DFMO is also effective against other parasitic protozoa, e.g.,
Plasmodium falciparum and Plasmodium berghei (2). It has
been demonstrated earlier that DFMO treatment results in
lowering of the intracellular polyamine content and has been
shown to be effective against promastigotes of the 1S strain of
Leishmania donovani (12). In addition to DFMO, several in-
hibitors of ODC, like 3-aminooxy-1-aminopropane (APA),
have been reported to be effective in blocking the proliferation
of parasites and tumor cells (9, 13, 14, 16, 25, 29).
In the present study we show for the first time the inhibitory
effect of APA, a competitive inhibitor of mammalian ODC, on
parasite growth, ODC activity, and cellular polyamine and
trypanothione [T(SH)2] concentrations in L. donovani. Fur-
thermore, the L. donovani ODC gene was used to generate
ODC overexpressers, and these ODC overexpressers proved to
be resistant to sodium antimony gluconate, pointing toward a
role for ODC overexpression in antimonial drug resistance. To
understand the role of ODC in antimonial drug resistance, we
analyzed the polyamine synthesis pathway in field isolates col-
lected from patients with visceral leishmaniasis who did not
respond to SAG treatment. All the SAG-resistant isolates
showed an increase in ODC activity concomitant with high
levels of putrescine and spermidine. Furthermore, the ODC
overproducers raised in the laboratory and clinical isolates
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resistant to sodium antimony gluconate were also resistant to
APA, confirming that ODC is the primary intracellular target.
MATERIALS AND METHODS
Chemicals. Growth media and antibiotics were purchased from Sigma (St.
Louis, MO), and fetal bovine serum (FBS) was purchased from Gibco/BRL (Life
Technologies, Scotland, United Kingdom). All other chemicals were of analytical
grade. Sodium antimony gluconate powder was obtained from Glaxo-Wellcome.
Parasite and culture conditions. Promastigotes of Indian Leishmania donovani
clone GE1 (MHOM/IN/80/GE1F8R) (1), Leishmania donovani strain (MHOM/
IN/80/AG83) (wild type), and three untyped clonal strains (strains S-1, R-1, and
R-2) were isolated from patients with VL and were routinely cultured at 22°C in
medium M-199 with Hanks’ salts, including 25 mM HEPES buffer (Sigma)
supplemented with 10% FBS and 100 g/ml gentamicin (Sigma).
Clinical isolates sensitive to SAG included S-1 and AG83, whereas the three
SAG-resistant isolates were GE1, R-1 and R-2. The SAG-resistant isolates were
maintained in the absence of drug pressure in vitro. The isolates have been
passaged through hamsters or BALB/c mice to retain their virulence; and im-
portantly, their chemosensitivity profiles have remained unchanged, as measured
periodically by the amastigote-macrophage infectivity assay described below.
Effect of drugs on cell growth. To estimate the 50% inhibitory concentrations
(IC50s) of the drugs, the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) micromethod was used, as described previously (15). Briefly,
late-log-phase promastigotes were seeded in a 96-well flat-bottom plate (200 l
per well; Nunc) in the presence or absence of drugs. To examine the effects of
exogenous polyamines, the cultures were additionally supplemented with 1 mM
putrescine or spermidine. After 72 h of incubation, MTT (10 mg/ml, 10 l per
well) was added to each well and the plates were incubated for an additional 4 h.
The enzyme reaction was then stopped by addition of acidic isopropanol (0.4 ml
10 N HCl in 100 ml isopropanol, 100 l per well), and the absorbances were
measured at 570 nm. Two or more independent experiments were performed in
triplicate for each drug.
DNA constructs and transfection. Construct pGEM7Zf-HYG-ODC, which
contains the ODC gene of L. donovani cloned into a Leishmania expression
vector (pGEM7Zf-HYG-) (6), and an episomal Leishmania expression vector
(pGL-NEOLUC) containing luciferase-encoding DNA and neomycin phos-
photransferase-selectable marker (26) were used in the present study. Clinical
isolates were transfected with pGL-NEOLUC. Twenty micrograms of the
construct was transfected into L. donovani promastigotes by electroporation in
2-mm-gap cuvettes at 450 V and 500 F (BTX Electro Cell Manipulator 600).
Transfectants were selected for resistance to either hygromycin B (100 g/ml) or
G418 (50 g/ml), as described previously (20). L. donovani strain AG83 was used
for overexpression of the L. donovani ODC gene by transfection. Transfectants
overexpressing ODC were routinely maintained in -minimum essential medium
supplemented with 50 g/ml hygromycin B. FBS was excluded to avoid poly-
amine oxidase-mediated toxicity (12).
Effects of drugs on amastigote-macrophage model. Stationary-phase Leishma-
nia promastigotes expressing the luciferase gene (pGL-NEOLUC) were used
to infect J774A.1 macrophages. Macrophage cell line J774A.1 (American Type
Culture Collection) was maintained at 37°C in RPMI 1640 medium (Sigma)
containing 10% FBS, as described previously (11). Briefly, J774A.1 murine mac-
rophages (1 105 cells/250 l/per well) were infected with 1 106 promastigotes
in medium M-199 with 10% FBS (26). After 3 h, the noninternalized parasites
were washed off and drug was added at different concentrations. After 5 days of
drug exposure, plates containing adherent macrophages were washed and lucif-
erase activity was determined (26). The IC50 was determined from a graph
representing different concentrations of drug plotted against the number of
relative light units produced by luciferase-expressing parasites.
Enzyme assay. L. donovani promastigotes (1  107) in late log phase were
treated with APA, and the cells were harvested 48 h later by centrifugation at
2,000  g for 15 min at 4°C. The cell pellet was washed with phosphate-buffered
saline (pH 7.4) and resuspended in 50 mM Tris-HCl (pH 7.5), 10 M EDTA,
and 2.5 mM dithiothreitol (DTT). The cells were lysed by freezing-thawing in
liquid nitrogen. The lysate was centrifuged at 15,000  g (20 min, 4°C), and the
supernatant was assayed for ODC activity and polyamine and protein concen-
trations. Protein concentrations were determined by the method of Bradford (3),
with bovine serum albumin used as the standard. ODC activity was assayed by
monitoring the release of 14CO2 from [L-14C]ornithine (24, 27). The standard
assay mixture, which contained the supernatant, 200 M pyridoxal phosphate,
12.5 mM DTT, 250 mM Tris (pH 7.5), 2 mM ornithine, and 3 Ci of the
radiolabeled ornithine, was incubated at 37°C for 1 h. The reaction was termi-
nated by injecting 5 N H2SO4; and the activity was expressed in enzyme units, in
which 1 unit is the number of nmol of CO2/mg protein/h.
Western blot analysis. Late-log-phase promastigotes (1 108) were harvested,
and the resultant cell pellet was resuspended in lysis buffer (morpholinepropane-
sulfonic acid [20 mM, pH 7.2], DTT [1 mM], phenylmethylsulfonyl fluoride [2
mM], and leupeptin and aprotinin [0.5 g ml1 each]). Promastigotes (wild type
and ODC overexpressers) were sonicated in the lysis buffer mentioned above,
and cell supernatants were prepared by centrifugation at 20,000  g. Aliquots
containing 50 g of protein were fractionated by sodium dodecyl sulfate-poly-
acrylamide gel electrophoresis and blotted onto a nitrocellulose membrane with
an electrophoretic transfer cell (Bio-Rad). Proteins were detected by the en-
hanced chemiluminescence method (Amersham Pharmacia Biotech). A poly-
clonal antibody (1:100 dilution) against purified L. donovani ODC, which was
generated in rabbits (kindly provided by Buddy Ullman, Portland, OR), was
used. Autoradiograms of the proteins were analyzed by using a model FLA 5000
imaging densitometer (Fuji, Japan). The results shown are representative of at
least three independent experiments.
Polyamine analysis. L. donovani promastigotes (1  107) were harvested at
48 h of growth by centrifugation at 2,000  g (15 min, 4°C). Quantitative
determination of the polyamines in acid extracts of L. donovani was performed
by C18 reversed-phase high-performance liquid chromatography after precolumn
derivatization with dansyl chloride (28).
Thiol analysis. Thiols were derivatized with monobromobimane and were
separated by high-performance liquid chromatography, as described elsewhere
(17).
Northern blot analysis. Total RNA was isolated from wild-type L. donovani
promastigotes (strain AG83, 2 108) and from ODC overexpressers by using the
TRI reagent (Sigma). For Northern blot analysis, 15 g of total RNA was
fractionated by denaturing agarose gel electrophoresis and transferred onto a
nylon membrane by standard procedures. Following the transfer of the RNA
onto nylon membranes, the nucleic acids were UV cross-linked to the membrane
in a Stratagene UV cross-linker. Prehybridization was done at 65°C for 4 h in a
buffer containing 0.5 M sodium phosphate, 7% sodium dodecyl sulfate, 1 mM
EDTA (pH 8.0), and 100 g/ml sheared and denatured salmon sperm DNA. The
blots were hybridized with a denatured [-32P]dCTP-labeled DNA probe (the
PCR probe comprised the L. donovani ODC-coding region) at 106 cpm/ml,
which was labeled by random priming (NEBlot kit; New England BioLabs). The
membranes were washed and air dried, visualized with a Fujifilm FLA-5000
imaging system, and quantified with ImageQuant software.
Statistical analysis. Data were statistically analyzed by the Student’s t test. The
data represent mean  standard deviations (SDs) of at least three determina-
tions from two independent experiments. A P value of 0.05 was considered
significant.
RESULTS
Effect of APA on growth of promastigotes and amastigotes.
L. donovani promastigotes were cultured in the presence of
increasing concentrations of APA. APA inhibited the growth
of promastigotes in a dose-dependent manner; the effective
concentration that caused 50% inhibition of growth (IC50)
after 72 h of drug addition was 42 M (Table 1). The sensi-
tivities of the amastigotes were tested in an intracellular amas-
TABLE 1. Effects of APA and DFMO on promastigotes and
amastigotes of Leishmania donovani and
macrophage cell line J774A.1
Inhibitor
IC50 (M)a
Promastigote Amastigote Macrophage cellline (J774A.1)
APA 42  8 5 2.1 200
DFMO 10,000 50 3.2 ND
a The results are the means  SDs of three independent experiments for all
data sets. IC50s for promastigotes were determined after 72 h of drug addition.
IC50s for intracellular amastigotes were determined after 5 days of drug addition.
IC50s for macrophage cell line J774A.1 were determined after 24 h of drug
addition. ND, not determined.
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tigote-macrophage model. The Leishmania expression vector
(pGL-NEOLUC) containing the luciferase gene was trans-
fected into the parasite, and the resulting transfectants were
used for susceptibility assays, as described in Materials and
Methods. The IC50 of APA for amastigotes after 5 days of drug
treatment was 5 M (Table 1). At these concentrations, APA
did not affect the viability of the macrophage cell line J774A.1,
with the IC50 being 200 M after 24 h of drug addition. The
L. donovani promastigotes and amastigotes exhibited higher
sensitivities to APA (at least 4.7- and 40-fold, respectively)
than the macrophage cell line J774A.1 did (Table 1). DFMO
inhibited amastigote growth in the macrophage model with an
IC50 of 50 M, but concentrations of DFMO as high as 10 mM
did not have any inhibitory effect on the promastigotes (Table
1). It is evident from Fig. 1A and B that addition of putrescine
(1 mM) or spermidine (1 mM) after 24 h or 48 h of drug
treatment resulted in reversal of the growth inhibition caused
by APA (50 M) in promastigotes.
Effects of APA on ODC activity and polyamine and trypano-
thione levels in promastigotes. APA inhibited the ODC activ-
ities of the L. donovani promastigotes (Fig. 2A). Treatment
with 50 M APA for 48 h inhibited ODC activity by 	76%.
Treatment with APA (50 M) for 48 h also resulted in the
concomitant reduction of putrescine and spermidine levels,
with 50 M APA resulting in an	70% reduction of putrescine
levels (Fig. 2B) and a 44% reduction of spermidine levels
compared to those for the untreated cells (Fig. 2B). APA (50
M) inhibited trypanothione levels by 	79% (Fig. 2C).
Characterization of L. donovani transfectants overexpress-
ing ODC. Promastigotes from the L. donovani AG83 strain
overexpressing ODC were isolated after transfection of an
episomal ODC gene construct, as described in Materials and
Methods. The growth patterns of the wild-type and ODC-
overexpressing cells were very similar, with population dou-
bling times of 	32 h and 	29 h, respectively (results not
shown). Northern blot analysis of total L. donovani RNA pre-
pared from promastigotes of the wild type and ODC overex-
pressers revealed the presence of the 4.8-kb and 6.5-kb ODC
transcripts in both cell lines (Fig. 3A). The presence of two
ODC transcripts in L. donovani species has been reported
earlier (8).
However, the 4.8-kb transcript was more abundant in the
ODC overexpressers than in the wild-type cells (	6.2-fold).
Interestingly, no major difference in the expression of the
6.5-kb transcript between the ODC-overexpressing and wild-
type cells was observed (Fig. 3A). Western blot analysis
showed that in the ODC-overexpressing cells there was an
increase in the level of ODC protein (	4.4-fold) compared to
that in wild-type promastigotes, which corresponded to a sim-
ilar difference in ODC activity (	3.8-fold) (Fig. 3B and C).
Although overexpression of ODC in the transfectants was ob-
served both by Northern analysis and by Western blot analysis,
the increase in the level of ODC mRNA expression was higher
than the increase in the level of the ODC protein. This dis-
crepancy may be due to posttranscriptional regulation, which
seems to be the mechanism of choice for gene expression in
Leishmania and other lower organisms (4).
The increased activity of ODC in the promastigotes of the
overexpressers resulted in a twofold increase in the putrescine
content compared to that in wild-type cells (Table 2), but no
corresponding difference in the spermidine content was ob-
served between the two cell lines. The absence of spermine in
both the wild type and the ODC overexpressers is consistent
with the previous observation that L. donovani lacks spermine
synthase (12). We also quantified the T(SH)2 levels in the wild
type and the ODC overexpressers (Table 2). Surprisingly, there
were no significant differences in the T(SH)2 levels between
the wild type and the ODC overexpressers.
A link between polyamine metabolism and antimony drug
resistance in leishmaniasis has been suggested (17, 32). To
evaluate whether the level of expression of ODC in L. dono-
vani affected sensitivity to the antimonial drug sodium anti-
mony gluconate, the effect of this drug was determined in the
wild-type and the ODC-overexpressing cell lines. As shown in
Table 3, the ODC overexpressers exhibited significant resis-
tance to sodium antimony gluconate compared to the resis-
tance of wild-type cells for both promastigotes and amasti-
gotes. The concentrations of sodium antimony gluconate that
FIG. 1. Reversal of APA-mediated promastigote growth inhibition
by exogenous polyamines. The L. donovani culture medium containing
an inhibitory concentration of APA was supplemented with 1 mM
putrescine (A) or 1 mM spermidine (B). Control cells were cultured in
the absence of APA. The growth of L. donovani was monitored over
120 h in the presence of 50 M APA. Putrescine at 1 mM (A) or
spermidine at 1 mM (B) was added after APA treatment for 24 h or
48 h. Parasites were enumerated every 24 h by counting with a hemo-
cytometer. The arrows indicate the times of addition of putrescine
(A) and spermidine (B). Each datum point represents the mean  SD
of three determinations. If the SD was5%, the means are not shown.
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inhibited growth of the wild-type promastiogtes and amasti-
gotes by 50% were 57 M and 15 M, respectively, whereas
the IC50s for promastiogtes and amastigotes of the ODC over-
expressers were 190 M and 76 M, respectively, indicating
that overexpression of ODC can confer resistance to antimo-
nials in both forms of the parasite. Similarly, the competitive
ODC inhibitor APA effectively inhibited growth, with the IC50s
being 42 M and 5 M for wild-type promastigotes and
amastiogotes, respectively (Table 3), and 155 M and 100
M for ODC-overexpressing promastigotes and amastigotes,
respectively (Table 3). In comparison, no difference in growth
inhibition was observed between the two cell lines when the
antitrypanosomal diamidine compound berenil was added to
the growth medium (IC50s, 	40 M for both cell lines [results
not shown]).
Characterization of ODC and polyamine and trypanothione
levels in promastigotes of clinical isolates. The sensitivities of
various clinical isolates to sodium antimony gluconate was
tested both in promastigotes and in intracellular amastigotes.
The IC50s of promastigotes of the wild-type strain and strain
FIG. 2. Effects of APA on ODC activity, polyamine pattern, and trypanothione levels of L. donovani promastigotes. (A) ODC activity,
(B) polyamine levels, and (C) trypanothione levels were determined as described in Materials and Methods. APA (50 M) was added to the
log-phase promastigotes, and cells were harvested 48 h later, as described in the Materials and Methods. Results are mean  SDs (n 
 3). a, the
values are significantly different from those for the controls, to which APA was not added (P  0.05).
FIG. 3. Analysis of ODC overexpression in promastiogtes of AG83
L. donovani derived by transfection with an episomal ODC gene con-
struct. (A) Northern blot analysis of the ODC transcripts in wild-type
(WT) and ODC-overexpressing (ODC) cells in log-phase growth (48
h) (top). Ethidium bromide-stained rRNA served as a loading control
(bottom). (B) The ODC protein contents of wild-type and ODC-
overexpressing cells in log-phase growth were determined by Western
blot analysis. The blot was probed with antibody against -tubulin to
normalize the loading onto each lane. (C) ODC activity was measured
radiometrically in wild-type and ODC-overexpressing cells in logarith-
mic growth. Data are means  SDs (n 
 3).
TABLE 2. Polyamine and trypanothione levels in wild-type and
ODC-overexpressing L. donovani promastigotes
Strain
Putrescine levela
(nmol/mg
protein)
Spermidine levela
(nmol/mg
protein)
Trypanothione
levelb
(nmol/108 cells)
Wild type 14.3  2.3 39.6 17.0 6.1  1.2
ODC overexpresser 27.5  4.3 42.0 6.5c 5.9  0.5c
a Polyamines were measured in acid extracts of promastigotes (strain AG83)
harvested at 48 h of growth. Data are means  SDs (n 
 3).
b Intracellular levels of trypanothione were measured by derivatization with
monobromobimane and separation by high-performance liquid chromatography.
Data are means  SDs (n 
 3).
c Not significantly different from the results for the wild type.
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S-1, which is a sensitive strain from a SAG-responsive patient,
were 57  0 and 47  5.6 M, respectively (Table 4), whereas
the IC50s of promastigotes from SAG-unresponsive patients
were 	1.4- to 3.4-fold higher than that for sensitive strain S-1
and ranged from 68 to 164 M (Table 4). The IC50s of sodium
antimony gluconate for amastigotes of the wild type and strain
S-1 were 15  6.0 and 13  1.5 M, respectively (Table 4),
whereas field isolates R-1, R-2, and GE1, which came from
SAG-unresponsive patients, had IC50s of 62  3.4, 23  1.4,
and95 M, respectively (Table 4). ODC activity in the SAG-
resistant promastigotes (strains R-1 and GE1) was 	2.0-fold
higher than that in SAG-sensitive promastigotes of strain S-1
(Table 5). However, strain R-2 had fivefold higher ODC ac-
tivities than SAG-sensitive strain S-1 (Table 5). The levels of
spermidine and its precursor, putrescine, were also measured
in the promastigotes of clinical isolates (Table 5). In SAG-
resistant strains R-1, R-2, and GE1, putrescine levels were 1.8,
3.4-, and 2.9-fold higher, respectively, than the level in SAG-
sensitive strain S-1. The levels of spermidine were 	1.6- to
1.9-fold higher in all the SAG-resistant isolates than in the
SAG-sensitive strain. However, there were no significant dif-
ferences in the T(SH)2 levels between the SAG-sensitive and
SAG-resistant isolates (Table 5).
The competitive ODC inhibitor APA was shown to effec-
tively inhibit the growth of amastigotes, with an IC50 of about
10 M for the SAG-sensitive amastigotes of strain S-1,
whereas concentrations of APA as high as 200 M did not
inhibit SAG-resistant amastigotes of strains R-1, R-2, and GE1
(Table 4). Thus, ODC overexpression in these clinically resis-
tant isolates alleviated the antiproliferative effects of APA.
DISCUSSION
The polyamine biosynthetic pathway is a potential target for
the development of new drugs with activities against parasitic
protozoa (18). The polyamines are essential for cell prolifera-
tion and differentiation, and interference with their biosynthe-
sis is an established strategy for the treatment of West African
trypanosomiasis caused by Trypanosoma brucei gambiense (18,
22). Recent results obtained with null mutants of L. donovani
in which genes in the polyamine biosynthetic pathway have
been silenced have clearly demonstrated that this pathway is
also a promising target for drugs with activities against the
protozoa that cause leishmaniasis (10, 23).
In the present study we examined the effect of APA, an
ODC inhibitor, on L. donovani growth. APA is a structural
analog of putrescine, and the aminooxy group in this com-
pound forms an oxime with the pyridoxal phosphate cofactor
in the active site of ODC. APA inhibited the growth of both
promastigotes in vitro and amastigotes in the macrophage
model, with the 50% inhibitory concentrations being 42 and 5
M, respectively. All drugs with activities against parasitic
organisms that cause disease should exhibit selective activity
against the pathogen and not the host; and in this regard, APA
at concentrations up to 200 M had no effect on macrophages,
thus establishing the usefulness of L. donovani ODC as a target
for the treatment of leishmaniasis. Earlier data on the effect of
APA on human T24 bladder carcinoma cells (IC50,	24.4 M)
(29) further confirm that Leishmania amastigotes exhibit
higher sensitivities to APA than the mammalian cells. The
antileishmanial effect of APA is mediated by the decrease in
ODC activity and putrescine and spermidine levels, as corrob-
orated by the abolition of antileishmanial activity following the
addition of putrescine or spermidine. It is likely that the effect
of putrescine is due to its conversion to spermidine, as has
been reported previously (25). In those studies, APA (50 M)
was found to significantly inhibit trypanothione levels in the
wild-type cells.
Surprisingly, in this study, addition of an irreversible inhib-
itor of ODC, DFMO, to promastigotes even up to a concen-
tration of 10 mM showed no effect on growth. In an earlier
study by Kaur et al. (12), DFMO was reported to cause poly-
amine depletion and growth inhibition of L. donovani promas-
tigotes. Interestingly, in the present study, DFMO inhibited
TABLE 3. IC50s for wild-type parasites and ODC-overproducing
parasites with sodium antimony gluconate and APA
Parasite form
IC50 (M)a
Wild type ODC overexpressers
Pentostam APA Pentostam APA
Promastigotes 57 0 42 8 190  0 155 16
Amastigotes 15 6 5  2 76 100
a The effects of sodium antimony gluconate and APA on the growth of pro-
mastigotes and amastigotes of wild-type and ODC-overexpressing L. donovani
strains are indicated as IC50s, which were determined as described in Materials
and Methods. The results are means  SDs (n 
 3).
TABLE 4. Comparative analysis of the susceptibilities of the sodium antimony gluconate-sensitive
and -resistant clinical isolates to sodium antimony gluconate and APAa
Isolate
IC50 (M)
Promastigotes Intracellular amastigotes
Sodium antimony gluconate APA Sodium antimony gluconate APA
Wild type 57  0 42  8 15.0  6.0 5 2.0
S-1 47 5.6 (1) 19  0.7 13.0  1.5 (1) 10 2.5
R-1 128 3.3 (2.7)* 400 62.0  3.4 (5)* 200
R-2 68 4.2 (1.4)* 46  2.8 23.0  1.4 (1.8)* 200
GE1 164 5.1 (3.4)* 400 95.0 (7.6)* 200
a Stationary-phase L. donovani isolates transfected with pGL-NEOLUC were used to infect J774A.1 macrophages, as described in Materials and Methods.
Luciferase activity was determined after 5 days of drug exposure. IC50s were determined from the graph representing the concentration of drug plotted against the
number of relative light units produced by luciferase-expressing parasites. IC50s are given as the means  SDs of at least three independent determinations. The fold
increase in the IC50 compared to that of strain S-1 is given in parentheses. *, The resistance levels observed in the SAG-resistant isolates are statistically different from
that in SAG-sensitive strain S-1 (P  0.002).
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amastigote growth in the macrophage model, with an IC50 of
50 M. Differences in sensitivities to DFMO and also to APA
between promastigotes and amastigotes is interesting and may
be due to differences in the uptake of the inhibitors. Amasti-
gotes of the L. donovani strain used in this study were shown to
be highly sensitive to the ODC inhibitors DFMO and APA,
which inhibited growth in the micromolar range. However,
APA was 10-fold more effective than DFMO against the amas-
tigote stage.
Previous results have shown that resistance to antimonial
compounds in Leishmania is multifactorial, with contributions
made by several independent mechanisms (6). A link between
polyamines and antimonial resistance has been suggested (19).
In trypanosomatids, like Leishmania, glutathione is replaced by
trypanothione, which is a conjugate between the polyamine
spermidine and glutathione. A correlation between resistance
to antimonial drugs and increased trypanothione levels ap-
pears to exist in Leishmania (17, 32). Thus, increased resis-
tance to antimonial drugs was found in cells that overproduce
trypanothione as a result of the increased expression of ODC
(7) or -glutamylcysteine synthetase (6), the rate-limiting en-
zyme of glutathione biosynthesis. A role of ODC in the devel-
opment of antimonial resistance is supported by our findings
that parasites overexpressing ODC after transfection of the
gene became more resistant to sodium antimony gluconate
than the wild-type cells. The ODC overexpressers expressed
high levels of ODC mRNA and an approximately fourfold
increase in ODC activity over that of the wild type. However,
there was only a twofold increase in putrescine levels and no
significant change in spermidine levels in the ODC overex-
pressers. No difference in trypanothione levels was observed
between the wild type and the ODC overexpressers. It is pos-
sible that this discrepancy could be due to the need to maintain
polyamines and trypanothione at constant intracellular levels.
These ODC overexpressers proved to be resistant to sodium
antimony gluconate, indicating a role of ODC overexpression
in drug resistance to an antimonial compound. ODC overex-
pressers exhibited significant resistance to APA. The wild-type
cells were more sensitive to APA than the ODC overexpress-
ers, indicating that the target was indeed ODC.
The resistance of clinical isolates of Leishmania donovani to
sodium antimony gluconate, the mainstay for the treatment of
Indian visceral leishmaniasis, has become a critical issue in
India. To understand the role of ODC and elevated levels of
polyamines in antimonial resistance, we looked into the poly-
amine synthesis pathway in the clinical isolates. ODC activities
were high in all three resistant isolates (strains R-1, R-2, and
GE1); and concomitantly, high levels of spermidine and pu-
trescine were also present, indicating that the resistance to
sodium antimony gluconate in the clinical isolates was associ-
ated with an increase in ODC activity and significant in-
creases in putrescine and spermidine levels. However, no
strict correlation between the degree of sodium antimony
gluconate resistance, as observed from the IC50s (Table 4),
and the corresponding levels of ODC activity in the clinical
isolates was observed (Table 5). Thus, it is possible that
ODC activity may explain the resistance to sodium antimony
gluconate only in part, and several other factors may be
responsible for the mechanism of resistance to sodium an-
timony gluconate. Surprisingly, no difference in the trypano-
thione levels was observed between the sensitive and the
resistant clinical isolates. This was also the case in the ODC
overexpressers reported in this study. Earlier reports also
showed no change in trypanothione levels in Leishmania
infantum isolates resistant to antimony [Sb(III)] (5). This is
possibly because the levels of T(SH)2 in the Leishmania
tarentolae strain studied are much lower than those in other
strains. It is also possible that the discrepancy observed in
the present study could be due to the need to maintain
trypanothione at a constant intracellular level. It has been
reported earlier that Sb(V) depletes T(SH)2 by efflux of the
Sb-trypanothione conjugate (5, 6, 17). This efflux system is
possibly enhanced in the resistant field strain, hence leading
to increased trypanothione efflux and thus explaining the
relatively constant level of trypanothione, despite the in-
crease in ODC activity and polyamine levels.
Our results demonstrate a link between ODC overexpres-
sion and antimonial resistance. We have also demonstrated
that APA is a potent inhibitor of L. donovani and that its
leishmaniacidal effect is due to inhibition of ODC. The inhib-
itory effect of APA on ODC activity correlates well with its
effect on parasite growth and depletion of putrescine and sper-
midine levels. Furthermore, the sodium antimony gluconate-
resistant clinical isolates exhibited significant resistance to
APA. However, APA exhibited selective activity against the
pathogen and not against the host, establishing the usefulness
of L. donovani ODC as a target for the treatment of leishman-
iasis.
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